• Profusa held a special shareholder meeting on June 23, 2026.
• Shareholders backed an amendment allowing the board to execute one or more reverse stock splits through June 23, 2028, up to 1-for-200.
• Investors authorized issuance of a new series of convertible preferred stock, plus conversion shares, to Bio Insights as acquisition consideration.
• Holders also cleared potential issuance above 19.99% of outstanding common stock upon conversion of a promissory note held by NorthView Sponsor I.
• Shareholders adopted an amendment to the 2025 Equity and Incentive Plan to increase the share pool, also approving authority to adjourn if needed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Profusa Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-070970), on June 23, 2026, and is solely responsible for the information contained therein.